PTC Therapeutics, Inc. announced that on Jan. 7, 2022, the company approved non-statutory stock options to purchase an aggregate of 18,255 shares of its common stock and 10,675 restricted stock units, each representing the right to receive one share of its common stock upon vesting, to 26 new employees.
January 13, 2022
· 2 min read